Evidence map›Paper›PMID 37410372›Full record

ArticleAIDS education and prevention : official publication of the International Society for AIDS Education2023

PrEP Persistence Support and Monitoring in Areas of High HIV Burden in the Midwestern United States.

Moira C McNulty, Jared Kerman, Samantha A Devlin, Maria Pyra, Laura Rusie, Kate Curoe, Liz Thompson, Joseph A Mason, Eleanor E Friedman, A Ziggy Uvin and 3 more

Abstract read
In one paragraph

Article in AIDS education and prevention : official publication of the International Society for AIDS Education, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Moira C McNultyDepartment of Medicine, Section of Infectious Diseases and Global Health, University of Chicago, Chicago, Illinois.
Jared KermanDepartment of Medicine, Section of Infectious Diseases and Global Health, University of Chicago, Chicago, Illinois.
Samantha A DevlinDepartment of Medicine, Section of Infectious Diseases and Global Health, University of Chicago, Chicago, Illinois.
Maria PyraDepartment of Medicine, Section of Infectious Diseases and Global Health, University of Chicago, Chicago, Illinois.
Laura RusieHoward Brown Health, Chicago, Illinois.
Kate CuroeDivision of Infectious Diseases, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri.
Liz ThompsonHoward Brown Health, Chicago, Illinois.
Joseph A MasonDepartment of Medicine, Section of Infectious Diseases and Global Health, University of Chicago, Chicago, Illinois.
Eleanor E FriedmanDepartment of Medicine, Section of Infectious Diseases and Global Health, University of Chicago, Chicago, Illinois.
A Ziggy UvinDepartment of Medicine, Section of Infectious Diseases and Global Health, University of Chicago, Chicago, Illinois.
C Hendricks BrownCenter for Prevention Implementation Methodology, Northwestern University, Chicago, Illinois.
John SchneiderDepartment of Medicine, Section of Infectious Diseases and Global Health, University of Chicago, Chicago, Illinois.
Rupa PatelDivision of Infectious Diseases, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri.

Funding

Virology and Immunology Technology CoreP30AI117943 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Michael E Newcomb · 2015 to 2026
$38.4M
INNOVATIVE IMPLEMENTATION RESEARCH METHODS COREP30DA027828 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BROWN, C. HENDRICKS, MUSTANSKI, BRIAN · 2011 to 2020
$11.4M
Implementation Science to Strengthen the Integrated Care Continuum in Getting to Zero ContextsK23MH118969 · NIMH · UNIVERSITY OF CHICAGO · PI MCNULTY, MOIRA · 2019 to 2022
$682k
NIAID NIH HHS P30 AI117943NIDA NIH HHS P30 DA027828NIMH NIH HHS K23 MH118969
6 · The paper itself

Abstract

Monitoring pre-exposure prophylaxis (PrEP) metrics can guide service delivery yet does not occur routinely. We developed a survey to understand current practices for monitoring PrEP at PrEP-providing organizations in Illinois and Missouri. The survey was distributed from September through November 2020; 26 organizations participated. Most respondents indicated ongoing efforts to screen for PrEP eligibility (66.7%), link to care (87.5%), and retain clients in care (70.8%); 70.8% reported collecting data on PrEP initiation, 41.7% on retention in care, and 37.5% on missed visits. Barriers to monitoring PrEP metrics included lack of IT support (69.6%), manual processes (69.6%), and lack of staff resources (65.2%). Most respondents offered clients support for PrEP retention and adherence and wanted to expand interventions for PrEP persistence, yet fewer monitored corresponding metrics. To enhance PrEP implementation, organizations should improve monitoring and evaluation of PrEP metrics along the entire continuum and respond with appropriate services to support clients.

Indexed as

Anti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisHumansMidwestern United StatesSurveys and QuestionnairesAnti-HIV AgentsadherenceEHEEnding the HIV EpidemicHIVpersistencepre-exposure prophylaxisPrEPPrEP care continuum

Identifiers

PMID37410372
PMCPMC10328557

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.